Sort
261,768 grants matching “gene therapy”
Inflammatory Mechanisms and Treatment Strategies for Atherosclerosis in HIV
$1,026,954Steven Kyle Grinspoon · Massachusetts General Hospital · R01 · FY2011 · HL
The Cancer Target Discovery and Development Network at UCSF
$1,026,728Michael T McManus · University Of California, San Francisco · U01 · FY2021 · CA
Hutchinson-Gilford Progeria syndrome--a model for the genetics of aging.
$1,026,686Michael Erdos · National Human Genome Research Institute · ZIA · FY2025 · HG
A Haplotype Map for Multiple Sclerosis
$1,026,670Stephen L Hauser · University Of California, San Francisco · R01 · FY2012 · NS
Mode of action of a new Tat HIV-1 inhibitor
$1,026,652Susana T Valente · University Of Florida · R01 · FY2022 · AI
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
$1,026,596Christian Furlan Freguia · Rise Therapeutics, Llc · R44 · FY2023 · AI
The mucosal immune system: effects of aging and chronic antigenic stimulation
$1,026,461Rita Brickman Effros · University Of California Los Angeles · R01 · FY2009 · AG
Biomarker and Phenotypic Risk Factors for Breast Cancer Lymphedema
$1,026,442Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2016 · CA
IL-15 in the immunotherapy of cancer
$1,026,376Kevin Conlon · Division Of Basic Sciences - Nci · ZID · FY2014 · CA
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
$1,026,258Amitabh Chak · Case Western Reserve University · U54 · FY2011 · CA
Clinical production of viral vectors for cancer gene therapy
$1,026,237Rachel Beyer · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Translational Development of Replication-Competent Retrovirus Vectors
$1,026,229Noriyuki Kasahara · University Of California Los Angeles · U01 · FY2010 · NS
The Northwestern University Cancer Health Equity Research SPORE (NU-CHERS)
$1,026,212Melissa A. Simon · Northwestern University At Chicago · P20 · FY2020 · CA
Modeling KRAS-Dependent Synthetic Lethality in Human Colon Organoids
$1,026,181Calvin J Kuo · Stanford University · U01 · FY2017 · CA
Understanding the pathogenesis of and identifying treatments for albinism
$1,026,020Brian Brooks · National Eye Institute · ZIA · FY2025 · EY
Patient-Derived Models of Prostate Cancer for Personalized Medicine
$1,026,019Nora M Navone · University Of Tx Md Anderson Can Ctr · U01 · FY2021 · CA
Neuroengineering a Robust Vocal Learning Phenotype in Mice as a Model for Treating Communication Disorders
$1,025,950Erich D Jarvis · Rockefeller University · R01 · FY2020 · DC
An integrated computational and functional genomics discovery engine for preclini
$1,025,918Christopher J Kemp · Fred Hutchinson Cancer Research Center · U01 · FY2015 · CA
Biomarker Investigations for Clinical Trials
$1,025,905Liang Cao · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
Immunological Analysis of Brain Cancer
$1,025,686Masaki Terabe · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Monoclonal Antibody Therapy for West Nile Virus
$1,025,666Michael S. Diamond · Washington University · U01 · FY2008 · AI
An innovative, non-thiazolidinedione pan-PPAR agonist therapeutic for alcoholic hepatitis: IND-enabling safety and toxicological evaluation
$1,025,643Prasad Manchem · Pleiogenix Inc. · R44 · FY2025 · AA
How do genome alterations cause human lung cancer?
$1,025,600Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2015 · CA
Mechanisms and Vulnerabilities of Aberrant Transcriptional Enhancers in Cancer
$1,025,513A Thomas Look · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Development of Transplant Strategies Uniquely Responsive to the Needs of Children
$1,025,475Allan D. Kirk · Emory University · U01 · FY2010 · AI